Concepedia

Sarah Arterburn

SA

Statistics

Publications

35

Citations

6.8K

H-Index

24

Active since

2000

Affiliations

Gilead Sciences (United States)(Current)

Medizinische Hochschule Hannover

Hôpital Beaujon

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

University of California, San Francisco

Sarah Arterburn is an author at Gilead Sciences (United States) specializing in medicine, viral hepatitis, and hepatitis.

Top concepts

Publications per year

2000–2023

35

Publications

35

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

Eric Lawitz, Alessandra Mangia, David Wyles et al. · New England Journal of Medicine · 2013 · 1.8K citations

Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years

Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote et al. · Gastroenterology · 2006 · 882 citations · Full text

, , +7

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

Michael Charlton, Gregory T. Everson, Steven L. Flamm et al. · Gastroenterology · 2015 · 795 citations · Full text

Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B

Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote et al. · New England Journal of Medicine · 2005 · 535 citations · Full text

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

Michael P. Manns, Didier Samuel, Edward Gane et al. · The Lancet Infectious Diseases · 2016 · 442 citations · Full text

, , +7

1–5 of 35